Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
Published Online: 2017-08-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alexander E Perl•Alexander I Spira•Andreas Neubauer•Catherine Smith•Celalettin Ustun•Chaofeng Liu•Christoph Röllig•David Claxton•Ellen Ritchie•Erkut Bahceci•Eunice S Wang•Gary Schiller•Giovanni Martinelli•Harry P Erba•Jessica K Altman•Jorge Cortes•Joseph G Jurcic•Maria R Baer•Mark Levis•Mark Litzow•Raoul Tibes•Richard A Larson•Robert Stuart•Stan Gill•Stephen A Strickland•Stuart Goldberg
